阿斯利康终止肺癌试验，石油巨头削减开支
Bloomberg Money Minute | AstraZeneca Halts Cancer Trial
This is a Bloomberg Money minute. Bad news for pharma giant AstraZeneca, as it has stopped a clinical trial of an experimental drug for lung cancer after did not help fight the disease better than existing therapies. The medicine was not faring better than the current blockbuster Keytruda. The drugmaker, though, does plan to continue to study the medicine and other cancers, including mesothelioma. Some of the largest oil companies in the world are dialing back their spending, in essence choosing profits over pumping.
这里是彭博财经一分钟。制药巨头阿斯利康传来坏消息，因其一款实验性肺癌药物在临床试验中未能比现有疗法更有效地对抗疾病，已停止该试验。该药物并未优于当前畅销药Keytruda。不过，这家药企计划继续研究该药物在其他癌症中的应用，包括间皮瘤。全球一些最大的石油公司正在缩减开支，实质上是在选择利润而非增产。
Chevron, ConocoPhillips and Occidental are among the companies cutting their spending on drilling and fracking in the U.S.. Instead, they use windfall from high crude prices to boost shareholder returns and pay down debt. Pet owners are spending money on experimental treatments they believe will help their furry friends live better and longer lives, including peptide injections, red light therapy and nutritional supplements.
雪佛龙、康菲石油和西方石油等公司正在削减在美国的钻探和水力压裂支出。相反，他们利用高油价带来的意外收益来提高股东回报和偿还债务。宠物主人们正花费资金尝试实验性治疗，相信这些治疗能帮助他们的毛茸茸伙伴活得更健康、更长久，包括肽注射、红光疗法和营养补充剂。
Spending on pets in the U.S. is expected to hit a record $165 billion this year. And finally, a lackluster start to the new week on Wall Street. With all three indices currently down, Dan Schwarzman Bloomberg.
美国今年宠物支出预计将达到创纪录的1650亿美元。最后，华尔街新的一周开局平淡。三大指数目前均下跌，丹·施瓦茨曼，彭博社报道。
更进一步：量化金融体系
看懂新闻只是起点——沿量化金融路径，把它变成能交付的工程能力